IDEXX Labs (IDXX) Tops Q3 EPS by 16c; updates outlook

IDEXX Labs (NASDAQ: IDXX) reported Q3 EPS of $2.53, $0.16 better than the analyst estimate of $2.37. Revenue for the quarter came in at $916 million versus the consensus estimate of $928.72 million.

GUIDANCE:

IDEXX Labs sees FY2023 EPS of $9.74-$9.90, versus the consensus of $9.83. IDEXX Labs sees FY2023 revenue of $3.64-3.65 billion, versus the consensus of $3.68 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c